NOVONCO THERAPEUTICS
Novonco Therapeutics is a company has since secured sponsored research and patent licensing agreements.
NOVONCO THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.novoncotherapeutics.com
Status:
Active
Contact:
1-310-806-9202
Technology used in webpage:
SPF IPv6 Google Apps For Business Google Maps Google Maps API Cloudflare Hosting Cloudflare DNS
Similar Organizations
iCo Therapeutics
ICo Therapeutics is focused on the research and development of drug delivery technologies.
Official Site Inspections
http://www.novoncotherapeutics.com
- Host name: 172.67.140.177
- IP address: 172.67.140.177
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novonco Therapeutics"
Novonco Therapeutics - Crunchbase Company Profile & Funding
Where is Novonco Therapeutics's headquarters? Novonco Therapeutics is located in Los Angeles, California, United States. Who are Novonco Therapeutics's competitors? Alternatives …See details»
Internationally noted oncologist Dr. Keith Black Joins Board of ...
NEW YORK, July 20, 2016 /PRNewswire/ -- Novonco Therapeutics (www.novoncotherapeutics.com) announced today that Dr. Keith Black has joined the Board of …See details»
Novonco Therapeutics Inc - Overview, Competitors, and …
View Novonco Therapeutics Inc (http://www.novoncotherapeutics.com) location in California, United States, revenue, competitors and contact information. Find and reach Novonco …See details»
Novonco’s Competitors, Revenue, Number of Employees, Funding …
Novonco’s Profile, Revenue and Employees. Novonco engages in the research and development of novel small molecules to treat solid and hematologic cancers. Novonco’s primary …See details»
Who we are - Novo Nordisk
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat serious chronic diseases, …See details»
Novo Nordisk | driving change to defeat serious chronic diseases
6 days ago · Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other …See details»
Novo Nordisk A/S | History, Structure, Products & Facts
1 day ago · Novo Nordisk A/S is an international pharmaceutical research, development, and manufacturing corporation established in 1989 through the merger of competing Danish …See details»
Novo Nordisk - LinkedIn
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our …See details»
Oncology dealmaking in 2021 - Nature
Mar 1, 2022 · Oncology-focused partnerships drove record-level licensing deals in 2021 as companies looked to gain access to novel therapeutic targets and platforms. Mike Ward is …See details»
OncoTherapeutics Company Profile 2024: Valuation, Investors ...
Operator of a research organization intended to develop immunotherapeutic drugs. The company's research services focus on the development and management of clinical trials and …See details»
Oligonucleotide Therapeutics Society - Home
Oligonucleotide therapeutics are now being used to successfully treat diseases and have the potential for widespread application. Over 100 treatments are in development for common …See details»
Oncotherapeutics - Crunchbase Company Profile & Funding
Oncotherapeutics is a full service Contract Research Organization (CRO) with a unique focus in oncology.See details»
Internationally Noted Oncologist Dr. Keith Black Joins Board Of ...
NEW YORK, July 20, 2016 /PRNewswire/ -- Novonco Therapeutics (www.novoncotherapeutics.com) announced today that Dr. Keith Black has joined the Board of …See details»
Methods and Techniques to Facilitate the Development of
Mar 29, 2021 · These studies indicate that C. novyi is uniquely poised to effectively accomplish the long sought after "holy grail" of oncotherapeutics: selective tumor localization via …See details»
About • ONCOtherapeutics
With more than 15 years experience as a full-service Contract Research Organization focused on hemeoncology drug development and improved utilization, we are dedicated to helping you …See details»
An intravenous pancreatic cancer therapeutic: Characterization of ...
Nov 14, 2023 · Clostridium novyi has demonstrated selective efficacy against solid tumors largely due to the microenvironment contained within dense tumor cores. The core of a solid tumor is …See details»
James R. Berenson, MD, Inc. Announces Rebranding and Changes ...
It is made up of three distinct yet integrated cancer research, diagnostic and treatment entities: Dr. Berenson’s internationally recognized patient practice; ONCOtherapeutics – a world-class …See details»
ONCOtherapeutics
We are a strategic Contract Research Organization (CRO) running multiple clinical trials in community oncology sites throughout the US. Uniquely focused on community-based …See details»
The next frontier of oncotherapy: accomplishing clinical translation …
Solid tumors present several challenges for current oncotherapeutics, including aberrant vascularization, hypoxia, necrosis, abnormally high pH and local immune suppression.See details»
Methods and Techniques to Facilitate the Development of …
Mar 28, 2021 · Clostridium novyi in particular has recently shown great promise in preclinical and clinical trials when administered directly to the tumor. These studies indicate that C. novyi is …See details»